Company Filing History:
1 out of 81 
1 out of 8 Years Active: 2009
Title: Homare Itou: Innovator in Hemoglobin A1c Determination
Introduction
Homare Itou is a notable inventor based in Aichi, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the determination of glycated hemoglobin.
Latest Patents
Itou holds a patent for a method of determining the glycated β-chain N-terminal of glycated hemoglobin. This innovative method utilizes enzymes to achieve specific determination without the need for separation operations. The patent also includes a determination reagent kit that employs a protease capable of cleaving glycated amino acids and peptides from the glycated β-chain N-terminal while preserving the integrity of the glycated α-chain N-terminal. This advancement allows for more efficient and accurate measurement of hemoglobin A1c levels.
Career Highlights
Throughout his career, Itou has worked with prominent companies such as Asahi Kasei Pharma Corporation and Ichibiki Co., Ltd. His experience in these organizations has contributed to his expertise in the field of enzymatic assays and medical diagnostics.
Collaborations
Itou has collaborated with notable colleagues, including Takeshi Matsuoka and Shinji Koga. Their combined efforts have furthered research and development in the area of glycated hemoglobin determination.
Conclusion
Homare Itou's innovative work in the field of hemoglobin A1c determination showcases his dedication to advancing medical diagnostics. His contributions have the potential to improve patient care and diagnostic accuracy in diabetes management.